Save your place

Sign in to WhoBought

Please try again later.

Oragenics, Inc. (OGEN) institutional ownership

Market cap$3.7M SectorHealthcare
Funds holding · Q1 2026
24
reported OGEN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
14 buyers · 10 sellers

Oragenics, Inc. (OGEN) price and institutional activity

Dates

Q1 2026

$0 bought by 14 investors
GeodePathstone Holdings, LLC +12 more
$0 sold by 10 investors
Drw Securities, LLCSabby Management, LLC +8 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Oragenics, Inc. (OGEN) institutional activity · 24

Investor Type Est. change Change Δ Own Date
Drw Securities, LLC · Exited
Change −113K Δ Own −100.0% Date Q1 2026
Drw Securities, LLC Exited· Q1 2026 −113K −100.0% Q1 2026
Geode · New
Change +65K Date Q1 2026
Geode New· Q1 2026 +65K Q1 2026
Sabby Management, LLC · Exited
Change −62K Δ Own −100.0% Date Q1 2026
Sabby Management, LLC Exited· Q1 2026 −62K −100.0% Q1 2026
Pathstone Holdings, LLC · New
Change +55K Date Q1 2026
Pathstone Holdings, LLC New· Q1 2026 +55K Q1 2026
Xtx Topco Ltd · Exited
Change −34K Δ Own −100.0% Date Q1 2026
Xtx Topco Ltd Exited· Q1 2026 −34K −100.0% Q1 2026
Two Sigma Securities, LLC · New
Change +20K Date Q1 2026
Two Sigma Securities, LLC New· Q1 2026 +20K Q1 2026
Hrt Financial LP · New
Change +19K Date Q1 2026
Hrt Financial LP New· Q1 2026 +19K Q1 2026
Virtu Financial LLC · New
Change +18K Date Q1 2026
Virtu Financial LLC New· Q1 2026 +18K Q1 2026
UBS Group AG · Added
Change +3K Date Q1 2026
UBS Group AG Added· Q1 2026 +3K Q1 2026
Ameritas Advisory Services, LLC · New
Change +2K Date Q1 2026
Ameritas Advisory Services, LLC New· Q1 2026 +2K Q1 2026
Western Wealth Management, LLC · New
Change +1K Date Q1 2026
Western Wealth Management, LLC New· Q1 2026 +1K Q1 2026
St. Johns Investment Management Company, LLC · New
Change +200 Date Q1 2026
St. Johns Investment Management Company, LLC New· Q1 2026 +200 Q1 2026
Morgan Stanley · Exited
Change −138 Δ Own −100.0% Date Q1 2026
Morgan Stanley Exited· Q1 2026 −138 −100.0% Q1 2026
Bank of America Corp · Exited
Change −37 Δ Own −100.0% Date Q1 2026
Bank of America Corp Exited· Q1 2026 −37 −100.0% Q1 2026
Tower Research Capital LLC (trc) · Reduced
Change −5 Date Q1 2026
Tower Research Capital LLC (trc) Reduced· Q1 2026 −5 Q1 2026
Data through Q1 2026 · filed May 27, 2026
15 of 24

Famous investor activity in Oragenics, Inc. (OGEN)

Oragenics, Inc. (OGEN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Spencer John · Officer Grant (A) 56K
Owned 56K Trade date Jul 1, 2026 Filed date Jul 7, 2026
Spencer John Officer Grant (A) 56K 56K Jul 1, 2026 Jul 7, 2026
Telling Fred · Director Sell −$197
Price $0.94 Qty −210 Owned 35K Trade date Dec 12, 2025 Filed date Dec 15, 2025
Telling Fred Director Sell $0.94 −210 −$197 35K Dec 12, 2025 Dec 15, 2025
Huffman Janet · Officer Grant (A) 250K
Owned 250K Trade date Dec 11, 2025 Filed date Dec 15, 2025
Huffman Janet Officer Grant (A) 250K 250K Dec 11, 2025 Dec 15, 2025
Giordano Natasha · Director 2 operations 163K
Owned 125K Trade date Dec 11, 2025 Filed date Dec 15, 2025
Giordano Natasha Director 2 operations 163K 125K Dec 11, 2025 Dec 15, 2025
Telling Fred · Director Grant (A) 125K
Owned 125K Trade date Dec 11, 2025 Filed date Dec 15, 2025
Telling Fred Director Grant (A) 125K 125K Dec 11, 2025 Dec 15, 2025
Gandolfo John P. · Director Grant (A) 125K
Owned 125K Trade date Dec 11, 2025 Filed date Dec 15, 2025
Gandolfo John P. Director Grant (A) 125K 125K Dec 11, 2025 Dec 15, 2025
Dunton Alan W. · Director Grant (A) 125K
Owned 125K Trade date Dec 11, 2025 Filed date Dec 15, 2025
Dunton Alan W. Director Grant (A) 125K 125K Dec 11, 2025 Dec 15, 2025
Koski Robert C. · Director Grant (A) 125K
Owned 125K Trade date Dec 11, 2025 Filed date Dec 15, 2025
Koski Robert C. Director Grant (A) 125K 125K Dec 11, 2025 Dec 15, 2025
Pope Charles L. · Director Grant (A) 125K
Owned 125K Trade date Dec 11, 2025 Filed date Dec 15, 2025
Pope Charles L. Director Grant (A) 125K 125K Dec 11, 2025 Dec 15, 2025
9 of 9

Oragenics, Inc. (OGEN) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Five Narrow Lane LP 82K
% of shares outstanding 10.0% Filing date Jul 2, 2025
Five Narrow Lane LP 82K 10.0% Jul 2, 2025
Sabby Management, LLC 413K
% of shares outstanding 9.9% Filing date Jan 21, 2026
Sabby Management, LLC 413K 9.9% Jan 21, 2026
2 of 2

Oragenics, Inc. (OGEN) ownership FAQ

Who owns OGEN?

24 reporting institutions disclosed OGEN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.